Characterization of acute HIV-1 infection in high-risk Nigerian populations

Journal of Infectious Diseases

Volumn 205, Issue 8, 2012, Pages 1239-1247

  Charurat, Man ^a   Nasidi, Abdulsalami ^b,c   Delaney, Kevin ^d   Saidu, Ahmed ^b   Croxton, Taelisha ^a   Mondal, Prosanta ^a   Aliyu, Gambo Gumel ^a   Constantine, Niel ^a   Abimiku, Alash'Le ^a   Carr, Jean K ^a   Vertefeuille, John ^d   Blattner, William ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b Nigerian Federal Ministry of Health   (Nigeria)

^c Reach Care Foundation   (Nigeria)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; VIRUS RNA;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE DURATION; FEMALE; GENE SEQUENCE; GENOTYPE; HIGH RISK POPULATION; HIV TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INFECTION CONTROL; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; NIGERIA; NUCLEIC ACID AMPLIFICATION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SEROCONVERSION; VIRUS CHARACTERIZATION; VIRUS LOAD;

ACUTE DISEASE; ADOLESCENT; ADULT; ANTI-HIV AGENTS; DRUG RESISTANCE, VIRAL; FEMALE; GENOTYPE; HIV INFECTIONS; HIV-1; HUMANS; MALE; MOLECULAR SEQUENCE DATA; NIGERIA; PHYLOGENY; RISK FACTORS; RNA, VIRAL; VIRAL LOAD; YOUNG ADULT;

EID: 84859089026     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jis103     Document Type: Article

References (28)

1. Cohen MS, Pilcher CD. Amplified HIV transmission and new approaches to HIV prevention. J Infect Dis 2005; 191:1391-3.
2. Blattner WA, Oursler KA, Cleghorn F, et al. Rapid clearance of virus after acute HIV-1 infection: correlates of risk of AIDS. J Infect Dis 2004; 189:1793-801.
3. Rong R, Li B, Lynch RM, et al. Escape from autologous neutralizing antibodies in acute/early subtype C HIV-1 infection requires multiple pathways. PLoS Pathog 2009; 5:e1000594.
4. Volberding P, Demeter L, Bosch RJ, et al. Antiretroviral therapy in acute and recent HIV infection: a prospective multicenter stratified trial of intentionally interrupted treatment. AIDS 2009; 23:1987-95.
5. Fiebig EW, Wright DJ, Rawal BD, et al. Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection. AIDS 2003; 17:1871-9.
6. Kassutto S, Maghsoudi K, Johnston MN, et al. Longitudinal analysis of clinical markers following antiretroviral therapy initiated during acute or early HIV type 1 infection. Clin Infect Dis 2006; 42:1024-31.
7. Ribeiro RM, Qin L, Chavez LL, Li D, Self SG, Perelson AS. Estimation of the initial viral growth rate and basic reproductive number during acute HIV-1 infection. J Virol 2010; 84:6096-102.
8. Constantine N, Saville RD, Dax EM. Retroviral testing and quality assurance: essentials for laboratory diagnosis. Ann Arbor, MI: Malloy Printers, 2005.
9. Pilcher CD, Fiscus SA, Nguyen TQ, et al. Detection of acute infections during HIV testing in North Carolina. N Engl J Med 2005; 352:1873-83.
10. Quinn TC, Brookmeyer R, Kline R, et al. Feasibility of pooling sera for HIV-1 viral RNA to diagnose acute primary HIV-1 infection and estimate HIV incidence. AIDS 2000; 14:2751-7.
11. Pilcher CD, McPherson JT, Leone PA, et al. Real-time, universal screening for acute HIV infection in a routine HIV counseling and testing population. JAMA 2002; 288:216-21.
12. Carr JK, Laukkanen T, Salminen MO, et al. Characterization of subtype A HIV-1 from Africa by full genome sequencing. AIDS 1999; 13:1819-26.
13. Salminen MO, Koch C, Sanders-Buell E, et al. Recovery of virtually fulllength HIV-1 provirus of diverse subtypes from primary virus cultures using the polymerase chain reaction. Virology 1995; 213:80-6.
14. Lar P, Bemis K, Jelpe D, et al. The genetic monitoring of HIV-1 subtypes in Jos Plateau State, Nigeria, In: International Conference on AIDS and STIs in Africa (ICASA). Nairobi, Kenya. September 21-26, 2003.
15. Smith SW, Overbeek R, Woese CR, Gilbert W, Gillevet PM. The genetic data environment an expandable GUI for multiple sequence analysis. Comput Appl Biosci 1994; 10:671-5.
16. Kumar S, Nei M, Dudley J, Tamura K. MEGA: a biologist-centric software for evolutionary analysis of DNA and protein sequences. Brief Bioinform 2008; 9:299-306.
17. Salminen MO, Carr JK, Burke DS, McCutchan FE. Identification of breakpoints in intergenotypic recombinants of HIV type 1 by bootscanning. AIDS Res Hum Retroviruses 1995; 11:1423-5.
18. Lole KS, Bollinger RC, Paranjape RS, et al. Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination. J Virol 1999; 73:152-60.
19. Gange SJ, Munoz A, Chmiel JS, et al. Identification of inflections in T-cell counts among HIV-1-infected individuals and relationship with progression to clinical. AIDS 1998; 95:10848-53.
20. Agwale SM, Zeh C, Paxinos E, et al. Genotypic and phenotypic analyses of human immunodeficiency virus type 1 in antiretroviral drug-naive Nigerian patients. AIDS Res Hum Retroviruses 2006; 22:22-6.
21. Agwale SM, Zeh C, Robbins KE, et al. Molecular surveillance of HIV-1 field strains in Nigeria in preparation for vaccine trials. Vaccine 2002; 20:2131-9.
22. Blattner WA, Oursler KA, Cleghorn F, et al. Rapid clearance of virus after acute HIV-1 infection: correlates of risk of AIDS. J Infect Dis 2004; 189:1793-801.
23. Cleghorn FR, Jack N, Carr JK, et al. A distinctive clade B HIV type 1 is heterosexually transmitted in Trinidad and Tobago. Proc Natl Acad Sci U S A 2000; 97:10532-7.
24. Hu DJ, Vanichseni S, Mastro TD, et al. Viral load differences in early infection with two HIV-1 subtypes. AIDS 2001; 15:683-91.
25. Kivela PS, Krol A, Salminen MO, et al. High plasma HIV load in the CRF01-AE outbreak among injecting drug users in Finland. Scand J Infect Dis 2005; 37:276-83.
26. Gray CM, Williamson C, Bredell H, et al. Viral dynamics and CD41 T cell counts in subtype C human immunodeficiency virus type 1-infected individuals from southern Africa. AIDS Res Hum Retroviruses 2005; 21:285-91.
27. Novitsky V, Wang R, Bussmann H, et al. HIV-1 subtype C-infected individuals maintaining high viral load as potential targets for the "test-and-treat" approach to reduce HIV transmission. PLoS One 2010 5:e10148.
28. Wawer MJ, Gray RH, Sewankambo NK, et al. Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda. J Infect Dis 2005; 191:1403-9.